Leonard D. Shultz
9Patents
1h-index
8Co-inventors
40Inventor score
Filing activity: Oct 17, 2008 → Jun 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10701911B2 | Genetically modified non-human animals and methods relating to complement dependent cytotoxicity | Human Necessities | 1 | Active |
| US11778994B2 | NSG mice lacking MHC class I and class II | Human Necessities | 1 | Active |
| US12409237B1 | Methods and models for assessing efficacy of immunotherapies | Human Necessities | 0 | Active |
| US11785923B2 | Genetically modified non-human animals and methods relating to complement dependent cytotoxicity | Human Necessities | 0 | Active |
| US9125384B2 | Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof | Human Necessities | 0 | Active |
| US9414576B2 | Genetically modified non-human animals and methods relating to innate immune system response detection | Physics | 0 | Active |
| US12378574B2 | Transgenic mouse models supporting innate immune function | Chemistry; Metallurgy | 0 | Active |
| US8431767B2 | Transgenic non-human animal and methods for stem cell engraftment | Human Necessities | 0 | Active |
| US10021861B2 | Genetically modified non-human animals and methods relating to innate immune system response detection | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.